China Health Technology Group Holding Company Limited, an investment holding company, engages in the forestry management business in the People's Republic of China. The company operates through Forestry Business, Ginseng Business, and Horny Goat Weed Business segments. The Forestry Business segment engages in the plantation, logging, and sale of timber related products. The Ginseng Business segment is involved in the ginseng plantation and trading of related products. The Horny Goat Weed Business segment engages in the horny goat weed plantation and trading of related products. The company was formerly known as China Bozza Development Holdings Limited and changed its name to China Health Technology Group Holding Company Limited in December 2023. China Health Technology Group Holding Company Limited was incorporated in 2009 and is headquartered in Shenzhen, China.
Frequently asked questions
What sector does China Bozza Development Holdings Limited (1069) operate in?
China Bozza Development Holdings Limited belongs to the Materials sector and operates in the Lumber & Wood Production industry.
What is China Bozza Development Holdings Limited (1069) current stock price?
As of the latest data, China Bozza Development Holdings Limited stock price is HK$0.25, with a previous close of HK$0.25.
What is China Bozza Development Holdings Limited (1069) current market capitalization?
China Bozza Development Holdings Limited market cap is approximately 40.14 million.
What is China Bozza Development Holdings Limited (1069) Earnings Per Share (EPS)?
The trailing EPS is HK$0.21.
What is China Bozza Development Holdings Limited (1069) Price-to-Earnings (P/E) ratio?
China Bozza Development Holdings Limited current P/E ratio is 1.18.
Does China Bozza Development Holdings Limited (1069) pay dividends?
No. China Bozza Development Holdings Limited does not pay a dividend.
What is China Bozza Development Holdings Limited (1069) beta (volatility) score?
China Bozza Development Holdings Limited has a beta of 1.018, meaning its volatility is roughly in line with the market.
